Rua Bioscience Limited (NZE:RUA)

New Zealand flag New Zealand · Delayed Price · Currency is NZD
0.0350
-0.0010 (-2.78%)
At close: Jan 30, 2026
16.67%
Market Cap11.83M +93.1%
Revenue (ttm)1.83M +477.4%
Net Income-3.46M
EPS-0.02
Shares Out338.04M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume30,452
Average Volume177,233
Open0.0360
Previous Close0.0360
Day's Range0.0340 - 0.0360
52-Week Range0.0230 - 0.0590
Beta0.40
RSI51.99
Earnings DateFeb 26, 2026

About Rua Bioscience

Rua Bioscience Limited engages in the research, development, and sale of pharmaceutical products in New Zealand and internationally. It offers cannabis-derived medicines. The company is also involved in seed production and genetic discovery related activities. In addition, it engages in plant breeding business, as well as involved in plant research activities. Rua Bioscience Limited was formerly known as Hikurangi Cannabis Company Limited and changed its name to Rua Bioscience Limited in October 2019. The company was founded in 2016 and is base... [Read more]

Sector Healthcare
Founded 2016
Employees 30
Stock Exchange New Zealand Stock Exchange
Ticker Symbol RUA
Full Company Profile

Financial Performance

In 2025, Rua Bioscience's revenue was 1.83 million, an increase of 477.39% compared to the previous year's 316,350. Losses were -3.46 million, -74.81% less than in 2024.

Financial Statements